| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to a conformationally restricted cyclic oligopeptide producing two stable and specific epitopes each of which is able to react with a target ligand, to a pharmaceutical composition comprising the above oligopeptide, and to a method for producing the oligopeptide. n EFFECT: producing the conformationally restricted cyclic oligopeptide. n 19 cl, 8 tbl, 8 ex |